RESUMO
This study was designed to determine the level of satisfaction, tolerance and perceived effectiveness by patients in the first pollen season after starting treatment with Alergovit(®). For this purpose, a nationwide, retrospective, multicentre and cross-sectional observational study was carried on 256 patients. Perceived effectiveness by the patients was measured using a visual analogue scale and was clinically significant in 92.4% of the patients. The satisfaction level was evaluated with a specific questionnaire. 32.5% of the patients were totally satisfied with Allergovit(®) and 48.8% reported a high degree of satisfaction. The treatment was well tolerated by 99.2% of the patients. Our results demonstrate that subcutaneous immunotherapy with Allergovit(®) is effective and well-tolerated in routine clinical practice.
Assuntos
Alérgenos/administração & dosagem , Antígenos de Plantas/administração & dosagem , Dessensibilização Imunológica/métodos , Satisfação do Paciente , Percepção , Rinite Alérgica Sazonal/terapia , Vacinas/administração & dosagem , Adolescente , Adulto , Alérgenos/efeitos adversos , Antígenos de Plantas/efeitos adversos , Biomarcadores/sangue , Criança , Pré-Escolar , Estudos Transversais , Feminino , Humanos , Imunoglobulina E/sangue , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Rinite Alérgica Sazonal/diagnóstico , Rinite Alérgica Sazonal/imunologia , Rinite Alérgica Sazonal/psicologia , Medição de Risco , Fatores de Risco , Espanha , Inquéritos e Questionários , Resultado do Tratamento , Vacinas/efeitos adversos , Adulto JovemRESUMO
No disponible
No disponible